Did you know that 80 percent of jobs never get posted or advertised? This is what some refer to as the hidden job market: jobs that are offered to people already known within the industry. As we discussed in part one of our blog series on breaking into the biotech and pharma industry, networking and making connections could be the best way to get your foot in the door.
Peter Dedivanovic joins Workforce Genetics as a Senior Life Sciences Talent Consultant
Are you looking to work in the biotech and pharmaceutical industry? Jeff Caskey, a senior life science talent consultant at Workforce Genetics was recently a featured speaker for Johns Hopkins University where he offered practical advice for breaking into the industry.
The pandemic turned the talent acquisition world on its head, forcing life science companies to adjust on the fly and move to a 100% virtual recruiting environment nearly overnight. While many industries saw layoffs, the life science industry saw a surge in hiring which made it even more important to get this new virtual shift right.
Join us for a lively discussion between our region’s top innovators and connectors to hear about their efforts to help grow the innovation ecosystem and the pipeline of successful startups across the BioHealth Capital Region.
Mark Aldridge joins Workforce Genetics as a Senior Life Sciences Talent Consultant to support the growth and expansion of the business in the Greater Philadelphia region.
Erica Gourdine, Life Science Recruiter at Workforce Genetics.
Industry Leaders Outline Best Strategies for Attracting Talent in the BioHealth Capital Region Recruiting and attracting talent is one of the top priorities and challenges for biotech and life science [….]
Ryan Hoover Joins Workforce Genetics as the Newest Talent Consultant for the Life Science Practice Ryan Hoover has joined Workforce Genetics as a Talent Consultant to support the company’s growing [….]
These are unprecedented times in which we are all experiencing radical changes and uncertainty due to the COVID-19 Pandemic. However, there is still expected to be a strong demand for [….]
